The U.S. Patent and Trademark Office issued BC3 Technologies, Inc. patent US12,263,185 for its hemostatic material and spray method of treating a bleeding wound of a human or an animal.

Hemostasis—the physiological process that stops bleeding—is a critical aspect of modern medical and surgical care. While the body is naturally equipped to control bleeding, certain clinical scenarios ...

designed for rapid arterial puncture closure following percutaneous catheter-based vascular procedures. Its novel mechanism of action reduces major vascular closure complications such as bleeding ...

This study was performed at the Shimane Medical University Hospital and the Shimane Prefectural Central Hospital, located in Izumo City (a mid-sized city in western Japan), which cover more than ...

This study shows that the incidence of hepatic encephalopathy was lower in cirrhotic patients with upper gastrointestinal bleed treated with lactulose as compared with patients not treated with ...

serving as either an alternative or an assistant to conventional hemostatic devices. These gels accelerate clotting, helping to stop or control bleeding more efficiently than the body’s natural ...

A special order item will need to ship to our warehouse from the manufacturer before then shipping to you. The estimated delivery range that you see is based on the information that we receive from ...

prothrombin complex concentrate had superior hemostatic efficacy and safety advantages to frozen plasma among patients requiring coagulation factor replacement for bleeding during cardiac surgery.

In this guide, we’ll cover the basics of wound healing, what services you can expect from a wound care provider, the latest technologies used, and tips to support healing at home.

PostGraduate Program in Molecular and Cellular Biology, Department of Physiological Sciences − Pharmacology, Biomedical Institute, Federal University of the State of Rio de Janeiro, Rio de Janeiro ...